Evidence map›Paper›PMID 40400111›Full record

ArticleMedical physics2025

A simulated annealing-based Bayesian network structure optimization framework for late morbidity prediction with a large prospective dataset.

Kailyn Stenhouse, Philip McGeachy, Sofia Spampinato, Kari Tanderup, Kathrin Kirchheiner, Kevin Martell, Sarah Quirk, Akila N Viswanathan, Michael Roumeliotis

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kailyn StenhouseDepartment of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada.
Philip McGeachyDepartment of Physics and Astronomy, University of Calgary, Calgary, Alberta, Canada.
Sofia SpampinatoDepartment of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Kari TanderupDanish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Kathrin KirchheinerDepartment of Radiation Oncology, Medical University Vienna, General Hospital Vienna, Vienna, Austria.
Kevin MartellDepartment of Oncology, University of Calgary, Calgary, Alberta, Canada.
Sarah QuirkDepartment of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.
Akila N ViswanathanDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Michael RoumeliotisDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.

Funding

Alberta InnovatesDanish Cancer Society R269-A15548Natural Sciences and Engineering Research Council of Canada
6 · The paper itself

Abstract

backgroundBayesian networks are seeing increased usage in healthcare, particularly for modeling complex treatment decisions under uncertainty. Bayesian networks offer significant advantages over classical machine learning and deep learning techniques due to their interpretability, with the network visualized through a directed acyclic graph outlining conditional relationships. Prior clinical knowledge can also be incorporated into these networks to enhance their clarity and facilitate integration into clinical workflows. However, out-of-box optimization techniques may produce networks that are not logically coherent or reflective of clinical understanding and may focus solely on optimizing information-based metrics without consideration for performance metrics crucial for developing predictive models. In late morbidity modeling, where the risk factors surrounding an outcome may be complex, intercorrelated, and not yet fully identified, it is important to have a customizable optimization approach to automatically produce logical, interpretable Bayesian networks that outline these complex outcomes. PURPOSE: Develop a simulated annealing-based framework for developing Bayesian network structures for late morbidity prediction in cervical cancer patients, addressing limitations of traditional optimization techniques and prioritizing interpretability.

methodsThis study utilizes the multi-center EMBRACE I cervical cancer dataset (n = 1153) to develop Bayesian network structures for late moderate-to-severe (grade ≥2) cystitis (CTCAEv.3) prediction. The dataset was split into training/validation data (80%) and holdout test data (20%). A process of 10 × 5-fold cross-validation was integrated into the optimization framework. A simulated annealing-based optimization method was developed incorporating information-theoretic measures, predictive performance measures, and complexity measures. The different network structures developed by this framework were compared in terms of complexity, interpretability, and predictive performance to optimization methods available out-of-box from the PyAgrum package for Python (Greedy Hill Climbing, Tree-Augmented Naïve Bayes, and Chow-Liu Optimization). Bayesian networks were also compared to conventional machine learning classifiers in terms of feature importance and predictive performance. Differences in model predictions arising from structure differences were assessed with Cochran's Q-test (p < 0.05).

resultsThe simulated annealing framework demonstrated the ability to produce Bayesian network structures with comparable or superior predictive performance compared to out-of-box models. A statistically significant performance difference was identified between the simulated annealing and out-of-box methods with Cochran's Q-test (p = 0.03). The simulated annealing approach equalled or outperformed out-of-box models on a bootstrapped holdout test set, with a balanced accuracy of 64.1%, an F1 macro score of 55.9%, and an ROC-AUC of 0.66. Simulated annealing models also featured fewer arcs and nodes, with this simplification resulting in networks that were easier to interpret without compromising on predictive performance, highlighting the effectiveness of simulated annealing in creating highly interpretable models for clinical use.

conclusionThe proposed simulated annealing-based framework represents a novel method for automatically generating Bayesian network structures for cervical cancer late morbidity modeling. Compared to out-of-box optimization techniques, the simulated annealing Bayesian networks provide comparable or superior predictive performance while constructing a more simple, interpretable network useful for clinical implementation.

Indexed as

Uterine Cervical NeoplasmsBayes TheoremFemaleHumansMorbidityProspective StudiesBayesian networkscervical brachytherapyhigh‐dose‐rate brachytherapymachine learningtoxicity prediction

Identifiers

PMID40400111
PMCPMC12149723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.